- 질문내용 -
A packet of envelopes azithromycin cost in the philippines "We rate shares 'market perform', reflecting a lack of confidence in Vical's pipeline candidates and a frustration with the slow pace at which Vical's DNA-based gene delivery platform has advanced," he said in a note.
|
|
